February 7, 2024
|
The Secretary, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Maharashtra, India. Scrip Code: 500470 |
The Manager, Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra, Mumbai - 400 051. Maharashtra, India. Symbol: TATASTEEL |
Dear Madam, Sirs,
Sub: Scheme of amalgamation amongst Tata Steel Limited and TRF Limited and their respective shareholders
This has reference to our disclosures dated September 22, 2022, and September 18, 2023, intimating the approval of the Board of Directors ('Board') and the shareholders respectively of Tata Steel Limited ('Company') of the scheme of amalgamation amongst Tata Steel Limited and TRF Limited and their respective shareholders ('Scheme').
In this connection, please find enclosed herewith an announcement from TRF Limited. The Board of Directors of TRF Limited has, for the reasons specified in the announcement enclosed, on February 6, 2024, decided to not to proceed with the proposed amalgamation and approved withdrawal of the Scheme. In concurrence with the decision of the Board of Directors of TRF Limited, the Board has also decided to withdraw the Scheme.
An application to withdraw the Scheme will be filed with Hon'ble National Company Law Tribunal, Mumbai Bench.
This disclosure is being made in terms of Regulation 30 read with Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with applicable SEBI Circulars.
This is for your information and record.
Yours faithfully,
Tata Steel Limited
Parvatheesam Kanchinadham
Company Secretary &
Chief Legal Officer (Corporate & Compliance)
Encl.: as above
http://www.rns-pdf.londonstockexchange.com/rns/3100C_1-2024-2-7.pdf
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
